Assessment of the e-Answers Initiative,a New Model for Response by Email to Scientific Information Requests Carried Out by the Medical Information Service of Novartis Pharmaceuticals in Spain

Abstract

Background:

The aim of this study was to evaluate internal customer satisfaction with the Medical Information Service of Novartis Farmacéutica after changing to a new model of response by email to scientific information requests (the e-Answers initiative).

Methods:

A survey, conducted 3 months after the e-Answers initiative was implemented, was designed to determine the profile of each respondent and included 10 multiple-choice questions on user satisfaction. A 7-point Likert-type scale was used whenever possible.

Results:

A total of 97 responses (50.5%) were analyzed. Overall satisfaction with the change was favorable for 94% of respondents, and 94% and 97% of respondents evaluated favorably the elimination of paper load and the decrease in environmental impact, respectively. Satisfaction with response time since implementing the new model was positive for 91% of the respondents.

Conclusion:

In this anonymous survey with high participation of service users, the e-Answers initiative was evaluated positively.

Keywords

medical information drug information service pharmaceutical industry satisfaction survey copyright

Get full access to this article

View all access options for this article.

References

Hoffman

Gumbhir

. Evaluation of an industry-based drug information service. Drug Inf J. 1993;27 (2):549–560.

Baker

. User survey of an industry-based drug information service. Drug Inf J. 1990;24 (1):235–243.

Rawn

. Hoffman-La Roche Ltd. Drug Information & Safety Department survey of customer needs and satisfaction. Drug Inf J. 1999;33 (2):525–539.

Collins

. Drug information services at Burroughs Wellcome Co. Am J Hosp Pharm. 1990;47 (9):1991–1993.

Magnuson

Buchanan

Quan

Teichman

. Drug information services at Genentech. Am J Hosp Pharm. 1990;47 (9):1993–1995.

Pfeil-Doyle

Jones

Oberlin

Benitez

Jr . Drug information services at Eli Lilly and Company. Am J Hosp Pharm. 1990;47 (9):1996–1998.

Gasperino

. Drug information services at Pfizer Labs. Am J Hosp Pharm. 1990;47 (9):1998–1999.

Baker

Gurwich

Depew

. Drug information services at The Upjohn Company. Am J Hosp Pharm. 1990;47 (9):1999–2001.

Bassin

Bilhuber

. Functioning of a medical information unit within a large pharmaceutical organization: a methodological approach and review. Drug Inf J. 1986;20 (1):165–172.

10.

Bauman

Fuentes

. Drug information at Glaxo Inc. Drug Inf J. 1989;23 (1):95–103.

11.

Fincham

. Response rates for surveys and responsiveness, standards, and the journal. Am J Pharm Educ. 2008;72 (1):1–3.